Cubist Systematic Strategies’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,064
Closed -$480K 3055
2020
Q4
$480K Sell
4,064
-273
-6% -$31.7K 0.01% 1794
2020
Q3
$482K Buy
4,337
+811
+23% +$87.1K 0.01% 1772
2020
Q2
$360K Buy
+3,526
New +$377K 0.01% 1763
2020
Q1
Sell
-2,819
Closed -$328K 2651
2019
Q4
$328K Buy
2,819
+2,168
+333% +$251K 0.01% 1804
2019
Q3
$75K Buy
651
+201
+45% +$20K ﹤0.01% 1981
2019
Q2
$43K Sell
450
-1,171
-72% -$110K ﹤0.01% 2340
2019
Q1
$148K Buy
+1,621
New +$133K ﹤0.01% 1905
2018
Q4
Sell
-1,548
Closed -$124K 2441
2018
Q3
$124K Buy
1,548
+1,148
+287% +$107K 0.01% 1565
2018
Q2
$40K Buy
+400
New +$34.6K ﹤0.01% 1663
2018
Q1
Sell
-5,549
Closed -$437K 2239
2017
Q4
$437K Buy
5,549
+932
+20% +$77.5K 0.02% 988
2017
Q3
$426K Buy
4,617
+1,952
+73% +$188K 0.02% 925
2017
Q2
$301K Sell
2,665
-2,494
-48% -$279K 0.02% 1032
2017
Q1
$517K Buy
5,159
+4,959
+2,480% +$530K 0.04% 617
2016
Q4
$22K Buy
+200
New +$23.4K ﹤0.01% 1633
2016
Q3
Sell
-378
Closed -$40K 2001
2016
Q2
$40K Buy
+378
New +$43.9K ﹤0.01% 1601
2015
Q3
Sell
-200
Closed -$23K 2150
2015
Q2
$23K Buy
+200
New +$21K ﹤0.01% 1752

Other funds holding CBPO

Cubist Systematic Strategies's CBPO Position: Q1 2021 in Review

Cubist Systematic Strategies sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 4,064 shares — an estimated $480K sold.

Cubist Systematic Strategies first reported a position in CBPO in Q2 2015 and held it in 16 quarters. The position peaked at $517K in Q1 2017. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Cubist Systematic Strategies reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 4,064 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $480K.
  • Cubist Systematic Strategies first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 16 quarters.
  • Cubist Systematic Strategies's China Biologic Products Holdings, Inc. position peaked at $517K in Q1 2017.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Cubist Systematic Strategies's 13F filing for Q1 2021, filed 17 May 2021.